Cargando…

Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States

BACKGROUND: Financial toxicity (FT) is a well-established side-effect of the high costs associated with cancer care. In recent years, studies have suggested that a significant proportion of those with atherosclerotic cardiovascular disease (ASCVD) experience FT and its consequences. OBJECTIVES: This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valero-Elizondo, Javier, Chouairi, Fouad, Khera, Rohan, Grandhi, Gowtham R., Saxena, Anshul, Warraich, Haider J., Virani, Salim S., Desai, Nihar R., Sasangohar, Farzan, Krumholz, Harlan M., Esnaola, Nestor F., Nasir, Khurram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352280/ https://www.ncbi.nlm.nih.gov/pubmed/34396329 http://dx.doi.org/10.1016/j.jaccao.2021.02.006

Ejemplares similares

Cumulative Burden of Financial Hardship From Medical Bills Across the Spectrum of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease Among Non‐Elderly Adults in the United States
por: Mszar, Reed, et al.
Publicado: (2020)

Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States
por: Mahajan, Shiwani, et al.
Publicado: (2021)

Association of cardiovascular risk factor profile and financial hardship from medical bills among non-elderly adults in the United States
por: Grandhi, Gowtham R., et al.
Publicado: (2020)

Measures of Financial Hardship From Health Care Expenses Among Families With a Member With Atherosclerotic Cardiovascular Disease in the US
por: Wang, Stephen Y., et al.
Publicado: (2022)

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions
por: Khera, Rohan, et al.
Publicado: (2020)

Variation and Disparities in Awareness of Myocardial Infarction Symptoms Among Adults in the United States
por: Mahajan, Shiwani, et al.
Publicado: (2019)

National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel Survey
por: Salami, Joseph A., et al.
Publicado: (2018)

Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study
por: Khera, Rohan, et al.
Publicado: (2018)

Heterogeneity in cardio-metabolic risk factors and atherosclerotic cardiovascular disease among Asian groups in the United States
por: Satish, Priyanka, et al.
Publicado: (2021)

Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012–2013 Medical Expenditure Panel Survey
por: Singh, Jai, et al.
Publicado: (2018)

Prevalence of and Sociodemographic Disparities in Influenza Vaccination Among Adults With Diabetes in the United States
por: Bhugra, Priyanka, et al.
Publicado: (2020)

Out‐of‐Pocket Annual Health Expenditures and Financial Toxicity From Healthcare Costs in Patients With Heart Failure in the United States
por: Wang, Stephen Y., et al.
Publicado: (2021)

Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus
por: Nargesi, Arash A., et al.
Publicado: (2021)

Unfavorable social determinants of health are associated with higher burden of financial toxicity among patients with atherosclerotic cardiovascular disease in the US: findings from the National Health Interview Survey
por: Valero-Elizondo, Javier, et al.
Publicado: (2022)

Atherosclerotic plaque in individuals without known cardiovascular disease but with established obstructive sleep apnea and at high risk of obstructive sleep apnea
por: Walia, Harneet K, et al.
Publicado: (2023)

Trends in 30-Day Readmission Rates for Medicare and Non-Medicare Patients in the Era of the Affordable Care Act
por: Angraal, Suveen, et al.
Publicado: (2018)

Influenza Vaccination Among Adults With CKD in the United States: Regional, Demographic, and Socioeconomic Differences
por: Grandhi, Gowtham R., et al.
Publicado: (2021)

The digital transformation of medicine can revitalize the patient-clinician relationship
por: Warraich, Haider J., et al.
Publicado: (2018)

Shared decision making and patient reported outcomes among adults with atherosclerotic cardiovascular disease, medical expenditure panel survey 2006–2015
por: Okunrintemi, Victor, et al.
Publicado: (2021)

Sex and Race Differences in the Utilization and Outcomes of Coronary Artery Bypass Grafting Among Medicare Beneficiaries, 1999–2014
por: Angraal, Suveen, et al.
Publicado: (2018)

Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expenditures Panel Survey
por: Salami, Joseph A., et al.
Publicado: (2017)

Determinants of Influenza Vaccine Uptake in Patients With Cardiovascular Disease and Strategies for Improvement
por: Bhugra, Priyanka, et al.
Publicado: (2021)

Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease
por: Agrawal, Tanushree, et al.
Publicado: (2021)

An Evaluation of the Vulnerable Physician Workforce in the United States During the Coronavirus Disease-19 Pandemic
por: Khera, Rohan, et al.
Publicado: (2020)

An Evaluation of the Vulnerable Physician Workforce in the USA During the Coronavirus Disease-19 Pandemic
por: Khera, Rohan, et al.
Publicado: (2020)

Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults—A population-level analysis in the national health interview survey
por: Nasir, Khurram, et al.
Publicado: (2022)

Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
por: Javed, Zulqarnain, et al.
Publicado: (2021)

Gender Differences in Patient‐Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease
por: Okunrintemi, Victor, et al.
Publicado: (2018)

Evaluation of the Anticipated Burden of COVID-19 on Hospital-Based Healthcare Services Across the United States
por: Khera, Rohan, et al.
Publicado: (2020)

Post-discharge acute care and outcomes following readmission reduction initiatives: national retrospective cohort study of Medicare beneficiaries in the United States
por: Khera, Rohan, et al.
Publicado: (2020)

Association of cardiovascular risk profile with healthcare expenditure and resource utilization in chronic obstructive pulmonary disease, with and without atherosclerotic cardiovascular disease
por: Jafar, Zain, et al.
Publicado: (2020)

Association Between Historical Neighborhood Redlining and Cardiovascular Outcomes Among US Veterans With Atherosclerotic Cardiovascular Diseases
por: Deo, Salil V., et al.
Publicado: (2023)

Availability of Clinical Trial Data From Industry‐Sponsored Cardiovascular Trials
por: Murugiah, Karthik, et al.
Publicado: (2016)

Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
por: Wheelock, Kevin M., et al.
Publicado: (2021)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

National Assessment of Statin Therapy in Patients Hospitalized with Acute Myocardial Infarction: Insight from China PEACE-Retrospective AMI Study, 2001, 2006, 2011
por: Zhang, Lihua, et al.
Publicado: (2016)

Political environment and mortality rates in the United States, 2001-19: population based cross sectional analysis
por: Warraich, Haider J, et al.
Publicado: (2022)

Trajectories of Risk for Specific Readmission Diagnoses after Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia
por: Krumholz, Harlan M., et al.
Publicado: (2016)

Sex-Specific Risk Factors Associated With First Acute Myocardial Infarction in Young Adults
por: Lu, Yuan, et al.
Publicado: (2022)

Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
por: Faridi, Kamil F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_etqke7hh9of1m300fsiirnfkjm